Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ganz

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
European Heart Journal|June 13, 2013
Endothelial dysfunction in coronary heart disease is more than a systemic processPeter Ganz, Priscilla Y Hsue
Journal of the American College of Cardiology|January 24, 2009
Individualized approach to the management of coronary heart disease: identifying the nonresponders before it is too latePeter Ganz, Priscilla Y Hsue
Science Translational Medicine|October 5, 2022
Response to comment on "A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk"Stephen A Williams, Peter Ganz
European Heart Journal|September 9, 2020
Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy GrailPeter Ganz, Rajat Deo, Ruth F Dubin
Circulation Journal : Official Journal of the Japanese Circulation Society|December 18, 2015
Behavioral Cardiovascular Risk Factors　- Effect of Physical Activity and Cardiorespiratory Fitness on Cardiovascular OutcomesRachel M Spencer, Bettina Heidecker, Peter Ganz
Journal of Pharmaceutical Sciences|March 29, 2002
Interactions of cyclosporines with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetryUwe Schote, Peter Ganz, Alfred Fahr, et al.
The American Journal of Cardiology|November 28, 2006
Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?Kausik K Ray, Christopher P Cannon, Peter Ganz
European Heart Journal|June 9, 2009
Structural and functional manifestations of human atherosclerosis: do they run in parallel?Peter Ganz, Jennifer E Ho, Priscilla Y Hsue
The American Journal of Cardiology|October 30, 2003
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromesGregory G Schwartz, Peter Ganz, David Waters, et al.
Biochemistry|February 26, 2004
Calorimetric measurement of phospholipid interaction with methyl-beta-cyclodextrinThomas G Anderson, Anmin Tan, Peter Ganz, et al.
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
European Heart Journal|June 13, 2013
Endothelial dysfunction in coronary heart disease is more than a systemic processPeter Ganz, Priscilla Y Hsue
Journal of the American College of Cardiology|January 24, 2009
Individualized approach to the management of coronary heart disease: identifying the nonresponders before it is too latePeter Ganz, Priscilla Y Hsue
Science Translational Medicine|October 5, 2022
Response to comment on "A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk"Stephen A Williams, Peter Ganz
European Heart Journal|September 9, 2020
Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy GrailPeter Ganz, Rajat Deo, Ruth F Dubin
Circulation Journal : Official Journal of the Japanese Circulation Society|December 18, 2015
Behavioral Cardiovascular Risk Factors　- Effect of Physical Activity and Cardiorespiratory Fitness on Cardiovascular OutcomesRachel M Spencer, Bettina Heidecker, Peter Ganz
Journal of Pharmaceutical Sciences|March 29, 2002
Interactions of cyclosporines with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetryUwe Schote, Peter Ganz, Alfred Fahr, et al.
The American Journal of Cardiology|November 28, 2006
Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?Kausik K Ray, Christopher P Cannon, Peter Ganz
European Heart Journal|June 9, 2009
Structural and functional manifestations of human atherosclerosis: do they run in parallel?Peter Ganz, Jennifer E Ho, Priscilla Y Hsue
The American Journal of Cardiology|October 30, 2003
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromesGregory G Schwartz, Peter Ganz, David Waters, et al.
Biochemistry|February 26, 2004
Calorimetric measurement of phospholipid interaction with methyl-beta-cyclodextrinThomas G Anderson, Anmin Tan, Peter Ganz, et al.
Pageof 20